Protein „AGEing”– cytotoxicity of a glycated protein increases with its degree of AGE-modification

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Zeitschrift für Gerontologie und Geriatrie (Print)

• Publication date

  2001-12-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s003910170018PMID 11828884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biochemistry of Neurodegeneration

  2001cited by this paper
• Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide.

  2000cited by this paper
• Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress

  1998cited by this paper
• Advanced glycation endproducts in ageing and Alzheimer's disease.

  1997cited by this paper
• APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1

  1997cited by this paper
• Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease.

  1996cited by this paper
• Age, neurofibrillary changes, Aβ-amyloid and the onset of Alzheimer's disease

  1996cited by this paper
• Advanced Maillard reaction end products are associated with Alzheimer disease pathology

  1994influential reference

• Current State of Research on the Mechanisms of Biological Activity of Alginates

  2025cites this paper
• Elucidating the Antiglycation Effect of Creatine on Methylglyoxal-Induced Carbonyl Stress In Vitro

  2024cites this paper
• Advances in Research on the Bioactivity of Alginate Oligosaccharides

  2020cites this paper
• Targeting Inflammatory Pathways in Alzheimer’s Disease: A Focus on Natural Products and Phytomedicines

  2019cites this paper
• The receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and exploiting common ground for novel amyloidosis therapies

  2018cites this paper
• RAGE-Specific Inhibitor FPS-ZM1 Attenuates AGEs-Induced Neuroinflammation and Oxidative Stress in Rat Primary Microglia

  2017cites this paper
• The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer’s Disease

  2015cites this paper
• N-Epsilon-(carboxymethyl)lysine is unable to induce endothelial dysfunction but is able to attenuate Ages-induced endothelium damage in human umbilical vein endothelial cells.

  2013cites this paper
• Differential effects of α-tocopherol and N-acetyl-cysteine on advanced glycation end product-induced oxidative damage and neurite degeneration in SH-SY5Y cells.

  2012cites this paper
• Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.

  2011cites this paper
• Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits.

  2011cites this paper
• Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury

  2011cites this paper
• Investigation into injury effects and related mechanisms of advanced glycation end-products on cortical neurons

  2011cites this paper
• Advanced glycation endproducts and their pathogenic roles in neurological disorders

  2010cites this paper
• Anti-inflammatory and anti-oxidant neuroprotection in the prevention of Alzheimer's disease

  2010cites this paper
• Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species.

  2010cites this paper
• Effects of plant-derived polyphenols on TNF-alpha and nitric oxide production induced by advanced glycation endproducts.

  2010cites this paper
• Diabetes : Starvation Amidst Plenty

  2009cites this paper
• Cytotoxicity of Maillard reaction products determined with a peptide spot library.

  2009cites this paper
• The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal

  2009cites this paper
• Identification of hydrogen peroxide as a major cytotoxic component in Maillard reaction mixtures and coffee.

  2009cites this paper
• Cellular Therapy Using Microglial Cells

  2007cites this paper
• Comparison of results of the CellTiter Blue, the tetrazolium (3-[4,5-dimethylthioazol-2-yl]-2,5-diphenyl tetrazolium bromide), and the lactate dehydrogenase assay applied in brain cells after exposure to advanced glycation endproducts.

  2007cites this paper
• Degradation of glycated bovine serum albumin in microglial cells.

  2006cites this paper
• Chronically active: activation of microglial proteolysis in ageing and neurodegeneration

  2005cites this paper
• Alzheimer’s associated inflammation, potential drug targets and future therapies

  2005cites this paper
• Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.

  2004cites this paper
• Glycation induces formation of amyloid cross-beta structure in albumin.

  2003cites this paper
• Advanced Glycation Endproducts Induce Changes in Glucose Consumption, Lactate Production, and ATP Levels in SH-SY5Y Neuroblastoma Cells by a Redox-Sensitive Mechanism

  2003cites this paper
• Glycation Induces Formation of Amyloid Cross-β Structure in Albumin*

  2003cites this paper